As of 2025-04-29, the Fair Value of Ramm Pharma Corp (RAMM.CN) is -0.64 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.02 CAD, the upside of Ramm Pharma Corp is -4,353.00%.
With the market price of 0.02 CAD and our fair value calculation, Ramm Pharma Corp (RAMM.CN) is not a good investment. Investing in RAMM.CN stocks now will result in a potential loss of 4,353.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 5Y Avg | |
| Net income | -7.43 | -7.11 | -20.96 | -7.72 | -16.50 | -11.94 |
| YoY growth | -8.95% | 4.36% | -194.93% | 63.16% | -113.73% | -50.02% |
| Market Cap (mil) | 1.79 |
| P/E | |
| Forward P/E |
| EPS | -0.13 |
| Avg earnings growth rate | -50.02% |
| TTM earnings | -15.23 |